| Model Number |
C111 |
| Medical Device Problem Codes |
Incorrect, Inadequate or Imprecise Result or Readings (1535); Material Integrity Problem (2978)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
01/11/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
There was an allegation of questionable a1c-3 tina-quant hemoglobin a1c gen.3 - whole blood and hemolysate application results for 1 patient sample on a cobas c 111 with ise module compared to a dca vantage analyzer.The initial a1c-3 result on the c111 analyzer was 10.30%.The hemoglobin a1c result on the dca analyzer was 11.9%.No questionable results were reported outside of the laboratory.The reagent lot number and expiration date were requested but not provided.
|
| |
|
Additional Manufacturer Narrative
|
|
The investigation is ongoing.
|
| |
|
Additional Manufacturer Narrative
|
|
No further information was provided.The investigation did not identify a product problem.The root cause of the event could not be determined.
|
| |
|
Search Alerts/Recalls
|